83396-73-0Relevant articles and documents
HIV protease inhibitors and intermediates
-
, (2008/06/13)
The present invention provides HIV protease inhibitors, intermediates for preparing HIV protease inhibitors. The enzyme, HIV protease, represents a viable target for the inhibition of HIV viral replication, thus providing a method for treating and/or prev
Protease inhibitors
-
, (2008/06/13)
The present invention provides novel HIV protease inhibitors, pharmaceutical formulations containing those compounds and methods of treating and/or preventing HIV infection.
Synthesis and Stereospecific Ring Opening of the (Z/E)-Isomers of 2-Methyl(Phenyl)-4-(thienylmethylene)-5(4H)-oxazolones
Cativiela, C.,Diaz de Villegas, M. D.,Mayoral, J. A.,Melendez, E.
, p. 899 - 902 (2007/10/02)
-